Introduction
Despite considerable progress over the past fifty years in the treatment of human malignancies, intrinsic and acquired resistance to chemotherapeutic agents and radiation remains a severe problem (Bernier et al., 2004; Chabner and Roberts, 2005) . Our understanding of mechanisms leading to therapeutic resistance has been expanded considerably during this time, and the crucial role of stress resistance pathways is increasingly recognized. It is now widely accepted that most cancer therapies work by inducing the intrinsic apoptotic pathway; however other mechanisms may also be involved, including activation of senescence, necrosis, mitotic catastrophe or autophagic cell death (Johnstone et al., 2002; Okada and Mak, 2004) . Altered expression or mutation of genes encoding key proteins involved in any of these processes can provide cancer cells with both an intrinsic survival advantage and inherent resistance to therapeutic-induced stress.
To identify novel genes and thus mechanisms by which tumor cells escape stress response, we have developed an approach in which tumor growth is accelerated by retroviral insertional mutagenesis, and subclones that have acquired stress resistance are selected. This approach takes advantage of the fact that retroviral infection of transgenic mice expressing the human MYC oncogene under control of the Igl enhancers, mimicking human Burkitt's lymphoma (Kovalchuk et al., 2000) , leads to the rapid development of polyclonal tumors. Retrovirus infection accelerates tumor progression by integration in the vicinity of oncogenes and/or tumor suppressor genes and their subsequent activation or inactivation, conferring a selective advantage and subsequent outgrowth of the affected cell (Mikkers and Berns, 2003) . In the approach developed here, the tumor cells are subsequently subjected to stress factors (ex vivo cultivation and g-radiation) prior to transplantation into recipient mice, thus providing a strong selective pressure for tumor cells with integrations that confer pro-survival mutations. The strength of this approach was demonstrated by identifying the known antiapoptotic factor Bcl-x L , but also identifying Gadd45b as a pro-survival factor in this system. Recent studies using gadd45b knockout mice have suggested an antiapoptotic function for Gadd45b (Gupta et al., 2005) . Extending these studies, we provide evidence that normal levels of Gadd45b may be critical to prevent apoptosis, but increased levels of Gadd45b contribute to tumorigenesis and tumor resistance by a mechanism distinct to classical apoptosis.
Results
Mouse model for the identification of tumor-related pro-survival genes To define genetic alterations that contribute to development of stress-resistant hematopoietic tumors in vivo, we extended the method of retroviral insertional mutagenesis in a mouse model for leukemia by adding an additional selection step. In the first step, we could show that infection of newborn El-MYC mice with Moloney-murine leukemia virus (Mo-MuLV) enhanced tumor progression and decreased the median survival Pro-survival function of Gadd45b in tumorigenicity A Engelmann et al time of the mice from 100 to 49 days ( Figure 1a ). Similarly to uninfected controls, the mice succumbed to an aggressive B-cell (B220
neoplasia, characterized by lymphoma and hepatosplenomegaly, as well as high leukocyte counts in the peripheral blood (mean 114 Â 10 6 cells ml À1 , n ¼ 44). The accelerated tumor progression can be attributed to additional oncogenic mutations caused by retrovirus integration.
To specifically select for tumor subclones in which mutations imparted a pro-survival advantage to stress stimuli, we explanted the tumors, cultivated the tumor cells ex vivo and exposed them to 7 Gy g-radiation, prior to their transplantation into syngenic recipient animals. Such treatments combine several stress stimuli and eliminate the vast majority of tumor cells by apoptosis as indicated by fragmentation of DNA and the presence of active cleaved caspase-3 (Figures 1b and c) . Although irradiation clearly provided the major death stimulus, ex vivo cultivation alone was sufficient to provoke a measurable apoptotic response in some tumor cells within a short time, indicating the sensitivity of primary tumor cells to non-genotoxic environmental changes.
In concordance with the massive cell death upon irradiation, tumor-initiating cells giving rise to secondary tumors were detected at a frequency four orders of magnitude lower than that of non-irradiated controls, as determined by serial dilution (Figure 1d ). Southern blot analysis performed with a Mo-MuLV env probe confirmed that the stress treatment induced a strong selection for specific clones; the viral integration pattern changed significantly from a predominantly diffuse picture in the parental primary tumor (P), indicative of a highly polyclonal tumor, to a more distinct band pattern in the different, primarily monoclonal, secondary tumors (S1-S9) (Figure 1e ). Of note, some bands not prominently appearing in the parental tumor could be detected in several of the different independent secondary tumors, with specific differences between the sets of non-irradiated and irradiated secondary tumors. This finding confirms that both treatments, ex vivo cultivation alone and ex vivo cultivation plus g-irradiation, provide a distinct selection pressure, selecting for different tumor cell clones.
A second round of radiation and re-transplantation of both irradiated and non-irradiated secondary tumors was performed to verify the selection for stress-resistant tumors (Figure 2a ). Although irradiation still delayed the in vivo growth of tumors cells selected for stress resistance (secondary tumors derived from irradiated primary cells), tumor growth was significantly faster and with a higher penetrance (95 versus 50%) than that of irradiated tumor cells derived from secondary tumors from non-irradiated primary cells (Figure 2b ). These results demonstrate that tumor cells had been selected that were significantly less sensitive to irradiation treatment. To determine if spontaneous mutations within the Trp53 gene were responsible for the acquired stress resistance, sequence analysis was performed. Only 25% of the tumors carried point mutations in the p53 coding region, in agreement with the low incidence of p53 inactivation in Mo-MuLV-induced murine and human lymphopathic tumors (Baxter et al., 1996; Krug et al., 2002) .
Integrations into the Bcl2l1 locus as a proof of principle To identify genetic alterations responsible for a prosurvival advantage in stress-resistant tumor cells, we analysed secondary tumors derived from ex vivo cultivated and irradiated primary tumors for viral integration sites. In total, 76 viral integration sites of 21 secondary tumors from 10 independent tumor sets were determined, and their specific location in the cellular genome was mapped (Supplementary data). Proviral insertions occurring in several, independently derived tumors are classified as common integration sites (CISs) and mark genes contributing to tumorigenicity (and progression), based on the fact that the frequency of finding two independent integrations in the same locus without a selective advantage would be too low to be detected (Mikkers and Berns, 2003) . The majority of CISs that we identified in secondary tumors have been described previously in MYC tumor mouse models (Table 1) . However, in addition, we found two loci, bcl2l1 and gadd45b, which have not been identified as a CIS in these models, but which were associated with stress-treated secondary transplants in our analysis.
Three independent integrations in two tumor sets were observed in the bcl2l1 locus, which codes for Bcl-x L . This is a bona fide antiapoptotic factor, being a member of the Bcl-2 family, which constitutes the master regulator controlling the intrinsic, mitochondria-mediated pathway of apoptosis (Tsujimoto, 2003) . Southern blot analysis of DNA isolated from one tumor set showed that integration into the bcl211 locus was present in two of three irradiated secondary tumors, while it was absent in all tumors derived from non-irradiated tumor cells and in the primary tumor ( Figure 3a) . Although the secondary tumors were derived from the same primary tumor, the integrations were independent events-occurring approximately 1000 bp from another, within the second intron of the bcl211 gene. A third integration was also detected in a secondary tumor arising from an independent primary tumor after irradiation. In this case, integration had occurred 300 bp upstream of the first coding exon. Quantitative reverse transcriptase (RT)-PCR confirmed that retroviral insertion into the bcl2l1 locus resulted in ca. 10-fold overexpression of Bcl-x L mRNA as compared to parental tumors (compare tumor P with S3 and S4 in Figure 3b ). However, upregulation was also observed in secondary tumors from the same set, in which no bcl211 integrations were detected (tumor S6). This may be due to integration in a region not detected by the probe, integration and dysregulation of a gene whose product regulates Bcl-x L expression, or to an unknown mechanism. Taken together, we found the Bcl2l1 locus to be a novel CIS characteristic of radiation-resistant tumors, leading to elevated levels of Bcl211 expression. 
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The gadd45b locus is a novel CIS From integrations in two independent tumor sets, we identified the gadd45b gene locus to be a novel CIS. Gadd45b is a member of the growth arrest and DNA damage-inducible Gadd45 family that is upregulated by various stress stimuli (Liebermann and Hoffman, 2002) . In one tumor set, several secondary tumors (four of five) from an irradiated primary tumor contained an integration 1.5 kb downstream of the gadd45b gene, which was not observed in five of seven secondary tumors that had developed from non-irradiated cells (Figure 4a ). No integration in this locus was detectable in the parental tumor. In a second independent tumor set, integration was detected 6.4 kb downstream of the gadd45b gene. This integration was detectable in three of four tumors derived from irradiated tumor cells, but not in the parental primary tumor (Figure 4b ). Northern blot and quantitative RT-PCR analyses showed that expression in tumors performing the integration was significantly elevated, with the exception of S19 (Figure 4c and data not shown). Also two tumors (S6, S7) without integration in this specific locus showed elevated gadd45b expression, suggesting alternative mechanisms for upregulation (see Discussion). Taken together, we found retroviral integrations into the gadd45b locus in two independent sets of tumors thereby clearly identifying this gene as a CIS. Significantly, integration and the resulting upregulation of Gadd45b expression were exclusively observed in secondary tumors, again indicative of a selection advantage that this integration confers to tumor cells that have been stressed by ex vivo cultivation with or without subsequent g-irradiation.
Gadd45b is an oncogenic pro-survival factor The finding that tumor cells with elevated Gadd45b levels are enriched upon stress treatment prompted us to ask whether high intracellular concentrations of this factor actively support tumorigenesis. To study the consequence of high Gadd45b expression, we stably expressed Gadd45b in NIH3T3 cells using a retroviral vector co-expressing enhanced green fluorescent protein (eGFP). The transduced cell population was enriched (75-95%) by flow cytometric sorting of GFP positive cells. Expression of Gadd45b and GFP in these cells was verified by western blot analysis (data not shown). Subcutaneous injection of 1 Â 10 6 Gadd45b expressing NIH3T3 cells reproducibly induced tumors in NOD/ SCID mice (n ¼ 10), which were clearly visible 15 days post injection (mean weight 0.5970.32 g; range 0.25-1.28 g). At the same time and up to the end of the observation period (21 days post injection), animals that had received parental-(n ¼ 9) or vector-transduced (n ¼ 9) NIH3T3 cells did not show any tumors. Overexpression of Gadd45b thus transforms NIH3T3 mouse fibroblasts and supports tumorigenesis. Moreover, these findings indicate that Gadd45b has an oncogenic activity, which is independent of deregulated MYC expression.
We speculated that the pro-tumorigenic potential of Gadd45b is due to inhibition of stress-induced cell death in a way similar to Bcl-x L . To address this, we analysed the impact of Gadd45b overexpression in several systems. DNA damage, as induced by high-dose irradiation, leads to apoptotic cell death by engaging the intrinsic mitochondria-mediated pathway. This can be measured via western blot analysis monitoring the presence of the cleaved and thereby active form of caspase-3 or assessing DNA fragmentation (% sub-G 1 ) by fluorescence-activated cell sorting (FACS) analysis. NIH3T3 fibroblasts exposed to two different doses of UV irradiation show the characteristics of apoptosis to varying degrees (Figures 5a and b) . As expected, overexpression of Bcl-x L completely blocked apoptosis. In contrast, Gadd45b overexpressing NIH3T3 cells underwent apoptosis upon UV treatment to the same extent as parental-or vector-transduced cells (Figures 5a  and b) . Similar results were obtained when murine hematopoietic Ba/F3 cells were subject to 6 Gy girradiation (Figure 5b) . We conclude that elevated Gadd45b levels do not protect against DNA damageinduced apoptosis mediated by the intrinsic pathway.
Another mechanism to induce cell death that might be relevant for our model system is activation of apoptosis Pro-survival function of Gadd45b in tumorigenicity A Engelmann et al as a direct consequence of MYC overexpression. Similar to DNA damage, deregulated MYC expression can also induce apoptosis via the intrinsic pathway, but the signaling upstream of the mitochondria is different.
To test whether overexpression of Gadd45b protects against MYC induced cell death, we took advantage of a murine hematopoietic cell line (ERP 15-41) that expresses a fusion protein coupling MYC to the Pro-survival function of Gadd45b in tumorigenicity A Engelmann et al estrogen receptor (MYC-ER) (Blyth et al., 2000) . Upon addition of 4-hydroxytamoxifen (4OHT), MYC-ER becomes activated and induces apoptosis as evidenced by DNA fragmentation and a high percentage of cells positive for propidium iodide (PI) staining (Figure 5c ). Overexpression of Bcl-x L also blocked MYC-induced cell death in these cells. No protective effect upon MYC activation, however, was observed in Gadd45b overexpressing cells, which behaved as the control cells. Thus, elevated Gadd45b levels do not confer a pro-survival effect by means of inhibiting the intrinsic pathway of apoptosis induced by DNA damage or activation of MYC.
Since integration in the gadd45b locus and elevated expression of its gene product was also observed in some secondary tumors that were not irradiated (see Figure 4) , we reasoned that Gadd45b might help the tumor cells to better survive non-genotoxic stress as a result of the ex vivo cultivation. To mimic this particular type of stress in a cell culture setting, we cultivated the differently transduced NIH3T3 fibroblasts in medium without serum. Serum withdrawal efficiently led to cell death of the vector-transduced control cells as evidenced by PI staining (Figure 6a) . Interestingly, overexpression of Bcl-x L provided only an initial, slightly protective effect against this stress stimulus, but could not prevent cell death. In striking contrast, Gadd45b expression prevented cell death under these conditions and maintained cell viability and growth ( Figure 6b ). As it has been reported that serum deprivation induces classical caspase-dependent apoptosis (Paddenberg et al., 2001) , we analysed the presence of cleaved and thus active caspase-3 in these cells (Figure 6c ). Cleaved caspase-3 was detectable in all serum-starved NIH3T3 cells, but, consistent with the ability of Bcl-x L but not Gadd45b to block the caspase pathway, levels were significantly reduced in cells expressing Bcl-x L (Figure 6c ). However, since only a small proportion of Gadd45b overexpressing cells died upon serum withdrawal, and Bcl-x L overexpressing cells died despite suppression of caspase-3 activation, we conclude that the major death pathway in NIH3T3 cells induced by serum withdrawal differs from known caspase-induced apoptosis. This conclusion is supported by other studies investigating the death pathway initiated by serum withdrawal (Simm et al., 1997; Kues et al., 2002; Leicht et al., 2003) . Gadd45b overexpression clearly protects against this yet to be identified death program. In summary, our data show that elevated levels of Gadd45b confer a potent and very specific protection against stress-induced cell death.
Discussion
The goal of this study was to define molecular mechanisms by which hematopoietic tumors escape Pro-survival function of Gadd45b in tumorigenicity A Engelmann et al stress-induced cell death. We established a powerful mouse model using retroviral insertional mutagenesis to identify genetic lesions that can abrogate cell death in lymphoid cells after induction of stress. One locus identified in this manner was mapped to the Bcl2l1 gene. This locus has been identified as a CIS in other mouse models (Packham et al., 1998; Hwang et al., 2002) , but has not been identified as a CIS for MYC mouse models. The finding that Bcl-x L expressing cells are protected against apoptosis induced by irradiation was not surprising. The protein belonging to the Bcl-2 family is a well-known antiapoptotic molecule, which blocks apoptosis at the level of the mitochondria and inhibits the release of apoptogenic molecules from the intermembrane space of the organelle (Tsujimoto, 2003) . Our findings are in accord with studies showing that elevated Bcl-x L levels correlate with therapy resistance of tumor cells from hematologic and solid tumors. The identification of the bcl2l1 locus as a CIS in secondary tumors after irradiation thus provides a satisfying 'proof-ofprinciple' to our approach.
The second CIS identified in this study was mapped to the gadd45b locus. This locus is a new retroviral CIS, since integrations in this locus have, to our knowledge, never been found in any mouse model. Integrations were primarily but not exclusively found in secondary tumors derived from irradiated primary tumor cells, leading to an approximately fivefold increase in expression levels. High expression of gadd45b was also observed in two secondary tumors that did not have integrations within the gadd45b locus. Owing to the extremely high levels of expression in these tumors, the integration sites of these two tumors were also cloned and sequenced. Interestingly, this analysis revealed integration in the tpl2 locus. Tpl2 is an activator of the transcription factor NF-kB (Das et al., 2005) , which is a well-known activator of gadd45b gene expression (De Smaele et al., 2001) . Thus the induction of gadd45b expression by NF-kB could account for the high expression levels. In summary, there appears to be a high selective advantage for upregulation of gadd45b in the development of tumors after stress, from either in vitro cultivation or irradiation.
One explanation for this is that Gadd45b acts as an oncogene during tumor progression, either alone or in combination with existing mutations. An oncogenic function was indeed demonstrated by assaying tumor development of fibroblasts engineered to overexpress Gadd45b in NOD/SCID mice. To determine whether it is also an antiapoptotic protein, the cells were also subjected to different apoptotic-inducing stimuli. Using two different cell lines, we could show that Bcl-x L but not Gadd45b overexpression protects cells from irradiation-induced apoptosis. Those findings were somewhat surprising, because, although Gadd45b was originally described as a pro-apoptotic protein in response to TGFb (Selvakumaran et al., 1994; Yoo et al., 2003) , more recent results have revealed antiapoptotic functions for gadd45b. Importantly, however, these studies have only demonstrated an antiapoptotic function for Gadd45b in the extrinsic apoptotic pathway (induced by stimulation with TNFa or Fas ligand) (De Smaele et al., 2001; Zazzeroni et al., 2003) or have inferred an antiapoptotic function by evaluating genotoxic-stressinduced apoptosis in gadd45b À/À bone marrow cells (Gupta et al., 2005 (Gupta et al., , 2006 . In accordance with our data, other work demonstrated that Gadd45b does not have an influence on apoptosis (Zerbini et al., 2004) .
Although high levels of Gadd45b were unable to protect cells from radiation or MYC-induced apoptosis, we were able to show that Gadd45b overexpression protected fibroblasts from cell death after serum withdrawal, showing that Gadd45b expression inhibits cell death under certain circumstances. Importantly, Gadd45b interferes with a cell death-inducing pathway that is different from the 'classical' caspase-3 driven apoptosis, which can be suppressed by Bcl-x L , indicating that the intrinsic pathway of apoptosis plays only a minor role upon serum withdrawal, and another, yet to be determined signaling cascade is the driving force to eliminate the cells under these conditions. Recent evidence suggests that besides apoptosis and senescence, therapeutic regimens can eliminate tumor cells by alternative pathways (Okada and Mak, 2004) . For example, it has been shown that cells protected from apoptosis by Bax and Bak knockout undergo necrosis or autophagic cell death in response to otherwise apoptotic stimuli (Lindsten et al., 2003; Shimizu et al., 2004) . It has also been suggested that the antitumor effect of mTOR inhibitors is mediated by their ability to induce autophagy, although it is unknown to what extent the autophagy-inducing effect of the mTOR inhibitors is involved in their antineoplastic activity (Kroemer and Jaattela, 2005) .
Many synergistic mechanisms may contribute to the elimination of tumor cells in the course of therapy and it is likely that inhibition of any one such mechanism results in escape of cell death. Our work shows for the first time a novel role for Gadd45b in the emergence of stress-resistant clones. The specificity of the Gadd45b-mediated effect and its difference to Bcl-x L support the hypothesis that different mechanisms act in concert to protect tumor cells from stress signals. Understanding these alternative cell death pathways will be important to develop alternative therapies to eliminate apoptosisresistant tumors.
Materials and methods

Mice, infections and tumor formation
Mice carrying the human MYC oncogene under the control of the Igl regulatory elements were crossed with wild-type C57BL/6 mice, and newborns were infected intraperitoneally within 24 h after birth with 0.05 ml Mo-MuLV-containing supernatant with a virus titer of 1.6 Â 10 6 infectivity units per milliliter. Non-transgenic littermates served as control in these experiments. Infected mice were monitored for lymphoma development, and killed when moribund. Cells dispersed from lymph nodes were transplanted (5 Â 10 6 cells or 5 Â 10 5 for the first and second transplantations, respectively, or after serial dilutions in RPMI1640) intraperitoneally into syngenic C57BL/6 recipients. To determine the tumorigenic potential of Gadd45b, 1 Â 10 6 transduced NIH3T3 cells in 100 ml PBS were injected subcutaneously into NOD/SCID mice.
Southern blot analysis of genomic DNA and isolation of integration sites High-molecular-weight genomic DNA was extracted from frozen tissue samples and subjected to Southern blot analysis by standard methods. For the analysis of apoptosis, highmolecular-weight DNA was extracted from 1 Â 10 7 tumor cells cultured for 3 h, as described (Heinrichs and Deppert, 2003) . Retroviral integration sites were isolated using a modified protocol of a previously described method (Schmidt et al., 2001) . Details are available upon request. Integrations were mapped to the murine genome using the BLAT and BLAST programs of the UCSC (http://genome.ucsc.edu/) and Ensembl (http://www.ensembl.org/) databases, respectively, and compared to known CISs in the RTCGD databank (http:// rtcgd.abcc.ncifcrf.gov/mm7/index.html).
RNA analysis
Total RNA was isolated from fresh or frozen tissue lysed in guanidine isothiocyanate and pelleted through a CsC1 cushion using the standard protocols. Northern blot analysis was performed using standard methods. To quantify expression levels, cDNA was produced with AMV reverse transcriptase (Promega, Mannheim, Germany) and subjected to real-time PCR using the LightCycler FastStart DNA Master SYBR Green I Kit (Roche, Penzberg, Germany). Conditions and primers are available upon request. Relative quantification of real-time PCR products was performed using the calibratornormalized method. Two independent experiments were performed in duplicates for each sample.
Cell culture and assays Cell lines were cultured under standard conditions in either DMEM or RPMI1640 media supplemented with 10% FCS and 4 mM glutamine, or in the case of Ba/F3 cells with interleukin-3. Induction of MYC was achieved by adding 250 nM 4-OHT (Sigma). Cells were subjected to UV irradiation in a UV-crosslinker (1800, Stratagene, La Jolla, CA, USA). g-irradiation was performed using a Cs 137 source. Viable cells were determined by PI exclusion and counted by FACS analysis. To determine sub-G 1 cell fraction, cells were fixed in 80% ethanol (À20 1C), stained with PI and analysed by FACS as described (Speidel et al., 2006) .
Production of retroviral supernatant and infection of cells
The coding regions of bcl2l1 and gadd45b were amplified via PCR (primers and conditions available upon request) and cloned into an FMEV-based retroviral vector (Schwieger et al., 2002) to generate pSF91-Bcl-x L (R1116) and pSF91-Gadd45b (R1117). Retroviral pseudo-types were produced as described (Schwieger et al., 2002) . Transduced cells were sorted for GFP-expressing cells with a FACS Aria (BD Biosciences, Heidelberg, Germany).
Western blot analysis
Cells were washed with ice-cold PBS, harvested and stored at À70 1C. Cells were lysed in 50 mM HEPES, pH 7.5, 150 mM NaCl, 0.1% NP40, supplemented with a proteinase inhibitor cocktail (complete mini, Roche). Sixty micrograms of lysate was separated on 13% SDS-PAGE gels. For western blotting and ECL we used standard protocols. Antibodies against the following antigens were used, that is, cleaved caspase-3 (9661; Cell Signalling, Danvers, MA, USA), tubulin (CP06; Oncogene/Calbiochem, San Diego, CA, USA), Bcl-x L (sc8392; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and Gadd45b (BC100; Novus Biologicals, Littleton, CO, USA).
Abbreviations
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